These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Male contraception: ideas for the future.
    Author: Cummings DE, Bremner WJ.
    Journal: Curr Ther Endocrinol Metab; 1997; 6():300-4. PubMed ID: 9174758.
    Abstract:
    Numerous global surveys have confirmed that men are willing to assume a more central role in family planning, especially if a wider range of contraceptive methods were available. At present, hormonal approaches to systemic male contraception represent the only hope for a marketable new technology within the next decade. Steroid regimens are reversible, inexpensive, free from major side effects, and can be delivered in convenient sustained-release formulations lasting several months. Gonadotropin-releasing hormone analogues are also promising. This article highlights recent advances in this important new area of research. All hormonal strategies require supplementation with androgens, whose long-term impact on lipid and prostate physiology needs further clarification. Unfortunately, research in the field of male contraception has been virtually abandoned by the pharmaceutical industry, which seems to underestimate men's interest in playing a more equitable role in family planning.
    [Abstract] [Full Text] [Related] [New Search]